Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-08

Clinical Trial Update: A Phase 1 Study of ADI-001 in Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ADI-001 for rheumatoid arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADI-001

Snippet

Sponsor: Adicet Therapeutics | Conditions: Rheumatoid Arthritis (RA) | Phase 1 | Status: RECRUITING